Cero Terapeutics Hldg Inc (CERO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 554 | 791 | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 0 | 1,050 |
| TOTAL | $846 | $1,098 | $N/A | $24 | $1,050 |
| Non-Current Assets | |||||
| Investments And Advances | 178,791 | 178,526 | 0 | 0 | 0 |
| Other Non-Current Assets | 87 | 153 | 0 | 277 | 0 |
| TOTAL | $178,879 | $178,679 | $N/A | $277 | $N/A |
| Total Assets | $179,725 | $179,777 | $N/A | $301 | $1,050 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 166 | 125 | 0 | 1 | 100 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 2,670 |
| TOTAL | $234 | $175 | $N/A | $277 | $2,770 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 187,650 | 187,650 | 0 | 0 | 0 |
| TOTAL | $187,650 | $187,650 | $N/A | $N/A | $N/A |
| Total Liabilities | $187,884 | $187,825 | $N/A | $277 | $2,770 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11 | 11 | 11 | 11 | N/A |
| Common Shares | 1 | 1 | N/A | 1 | 100 |
| Retained earnings | -8,160 | -8,048 | N/A | -1 | N/A |
| TOTAL | $-8,159 | $-8,048 | $N/A | $24 | $33,830 |
| Total Liabilities And Equity | $179,725 | $179,777 | $0 | $301 | $36,600 |